Alnylam Pharmaceuticals, Inc. (ALNY)
156.65
-3.20
(-2.00%)
USD |
NASDAQ |
Nov 12, 16:00
159.00
+2.35
(+1.50%)
After-Hours: 20:00
Alnylam Pharmaceuticals Price to Book Value : 5.819 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 5.819 |
| November 11, 2026 | 5.938 |
| November 10, 2026 | 5.633 |
| November 09, 2026 | 5.818 |
| November 06, 2026 | 5.793 |
| November 05, 2026 | 5.820 |
| November 04, 2026 | 5.984 |
| November 03, 2026 | 5.940 |
| November 02, 2026 | 5.869 |
| October 30, 2026 | 6.129 |
| October 29, 2026 | 6.464 |
| October 28, 2026 | 8.633 |
| October 27, 2026 | 8.425 |
| October 26, 2026 | 8.457 |
| October 23, 2026 | 8.322 |
| October 22, 2026 | 8.443 |
| October 21, 2026 | 8.362 |
| October 20, 2026 | 8.570 |
| October 19, 2026 | 8.666 |
| October 16, 2026 | 8.612 |
| October 15, 2026 | 8.694 |
| October 14, 2026 | 8.339 |
| October 13, 2026 | 8.314 |
| October 12, 2026 | 8.433 |
| October 09, 2026 | 8.644 |
| Date | Value |
|---|---|
| October 08, 2026 | 8.341 |
| October 07, 2026 | 8.336 |
| October 06, 2026 | 8.319 |
| October 05, 2026 | 8.168 |
| October 02, 2026 | 8.162 |
| October 01, 2026 | 8.588 |
| September 30, 2026 | 9.166 |
| September 29, 2026 | 25.09 |
| September 28, 2026 | 25.22 |
| September 25, 2026 | 25.28 |
| September 24, 2026 | 24.65 |
| September 23, 2026 | 24.35 |
| September 22, 2026 | 24.85 |
| September 21, 2026 | 24.13 |
| September 18, 2026 | 23.66 |
| September 17, 2026 | 24.25 |
| September 16, 2026 | 23.64 |
| September 15, 2026 | 23.53 |
| September 14, 2026 | 24.69 |
| September 11, 2026 | 24.56 |
| September 10, 2026 | 24.44 |
| September 09, 2026 | 25.48 |
| September 08, 2026 | 25.69 |
| September 04, 2026 | 26.28 |
| September 03, 2026 | 26.12 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ionis Pharmaceuticals, Inc. | 11.55 |
| Vertex Pharmaceuticals, Inc. | 6.580 |
| Pfizer Inc. | 1.846 |
| BridgeBio Pharma, Inc. | -- |
| Cerenome, Inc. | 1.031 |
Price to Book Value Related Metrics
| PE Ratio | 7.912 |
| PS Ratio | 4.303 |
| PEG Ratio | 0.0033 |
| Price to Free Cash Flow | 28.68 |
| Price | 156.65 |
| Earnings Yield | 12.64% |
| Market Cap | 20.97B |
| PEGY Ratio | 0.0033 |
| Operating PE Ratio | 22.07 |
| Normalized PE Ratio | 8.200 |